[Effect of hypnosis and autogenic training on acral circulation and coping with the illness in patients with progressive scleroderma].
In 12 patients with systemic sclerosis the influence of hypnosis and autogenic training on the acral blood circulation and the coping with the disease was investigated in a pilot study. In the first step significant increases in the skin temperature of the finger (mean +/- SD: 3.9 +/- 1.2 degrees C) could be found after relaxation hypnosis. In the second step six patients (study group) gained experience with autogenic training. The other six patients served as control group. In the study group, the skin temperature of the fingers (short-term effect) was significantly higher than in the control group (1.9 +/- 1.0 degrees C). Long-term effects of the autogenic training (mean acral rewarning time, duration and course of the Raynaud attacks, acral lesions of the hands, psychosomatic status of complaints, type of relation to the disease as precondition for coping with the disease) were not found within the relatively short follow-up period of 4 months. Two patients, however, reported that they could shorten the duration of Raynaud attacks by autogenic training. In our patients heterogenicity and an increased score of multiple psychosomatic complaints were registered at the outset. As far as the type of relation to the disease is concerned, the patients could be assessed as almost adapted. Hypnosis and autogenic training can be recommended as complementary therapy in systemic sclerosis.
Seikowski
K
K
Klinik und Poliklinik für Hautkrankheiten, Universität, Leipzig.
Weber
B
B
Haustein
U F
UF
D000223:Adaptation, Psychological / Q000502:physiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D001143:Arousal / Q000502:physiology; D001326:Autogenic Training; D003131:Combined Modality Therapy; D005260:Female; D005385:Fingers / Q000098:blood supply*; D005500:Follow-Up Studies; D006801:Humans; D006990:Hypnosis; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011602:Psychophysiologic Disorders / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D011928:Raynaud Disease / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D012039:Regional Blood Flow / Q000502:physiology; D012595:Scleroderma, Systemic / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D012803:Sick Role; D012881:Skin Temperature / Q000502:physiology*